BETA-BLOCKADE PREVENTS RECURRENT GASTROINTESTINAL-BLEEDING IN WELL-COMPENSATED PATIENTS WITH ALCOHOLIC CIRRHOSIS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL

被引：91
作者：
COLOMBO, M [1 ]
DEFRANCHIS, R [1 ]
TOMMASINI, M [1 ]
SANGIOVANNI, A [1 ]
DIOGUARDI, N [1 ]
机构：
[1] UNIV MILAN,SCH LIVER DIS,I-20122 MILAN,ITALY
来源：
HEPATOLOGY | 1989年 / 9卷 / 03期
关键词：
D O I：
10.1002/hep.1840090315
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：433 / 438
页数：6
相关论文
共 24 条
[1]   PHARMACOLOGY OF PROPRANOLOL IN PATIENTS WITH CIRRHOSIS AND PORTAL-HYPERTENSION [J].
ARTHUR, MJP ;
TANNER, AR ;
PATEL, C ;
WRIGHT, R ;
RENWICK, AG ;
GEORGE, CF .
GUT, 1985, 26 (01) :14-19
[2]   REDUCTIONS IN PORTAL PRESSURE BY SELECTIVE BETA-2-ADRENOCEPTOR BLOCKADE IN PATIENTS WITH CIRRHOSIS AND PORTAL-HYPERTENSION [J].
BIHARI, D ;
WESTABY, D ;
GIMSON, A ;
CROSSLEY, I ;
HARRY, J ;
WILLIAMS, R .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :753-757
[3]   INFLUENCE OF THE DEGREE OF LIVER-FAILURE ON SYSTEMIC AND SPLANCHNIC HEMODYNAMICS AND ON RESPONSE TO PROPRANOLOL IN PATIENTS WITH CIRRHOSIS [J].
BRAILLON, A ;
CALES, P ;
VALLA, D ;
GAUDY, D ;
GEOFFROY, P ;
LEBREC, D .
GUT, 1986, 27 (10) :1204-1209
[4]  
BRANCH RA, 1975, BR J CLIN PHARM, V2, P183
[5]   CONTROLLED TRIAL OF PROPRANOLOL FOR THE PREVENTION OF RECURRENT VARICEAL HEMORRHAGE IN PATIENTS WITH CIRRHOSIS [J].
BURROUGHS, AK ;
JENKINS, WJ ;
SHERLOCK, S ;
DUNK, A ;
WALT, RP ;
OSUAFOR, TOK ;
MACKIE, S ;
DICK, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (25) :1539-1542
[6]  
COLMAN JC, 1982, LANCET, V2, P1040
[7]   UPPER GASTROINTESTINAL-BLEEDING IN PATIENTS WITH PORTAL-HYPERTENSION - A REAPPRAISAL [J].
DAVE, P ;
ROMEU, J ;
MESSER, J .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1983, 5 (02) :113-115
[8]   NADOLOL FOR PREVENTION OF VARICEAL REBLEEDING IN CIRRHOSIS - A CONTROLLED CLINICAL-TRIAL [J].
GATTA, A ;
MERKEL, C ;
SACERDOTI, D ;
BOLOGNESI, M ;
CAREGARO, L ;
ZUIN, R ;
ANGELI, P ;
RUOL, A .
DIGESTION, 1987, 37 (01) :22-28
[9]  
HILLON P, 1982, HEPATOLOGY, V2, P528
[10]   CLINICAL-EXPERIENCE WITH ATENOLOL IN PATIENTS WITH CHRONIC LIVER-DISEASE [J].
KIRCH, W ;
SCHAFERKORTING, M ;
MUTSCHLER, E ;
OHNHAUS, EE ;
BRAUN, W .
JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (04) :171-177
123